Research Topics
Genomes and Genes
| T NaoeSummaryAffiliation: Nagoya University Country: Japan Publications
| Collaborators
|
Detail Information
Publications
Gene mutations of acute myeloid leukemia in the genome eraTomoki Naoe
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 97:165-74. 2013..Comprehensive genome research will deepen the understanding of AML to promote the development of new classification and treatment. This review focuses on gene mutations that were recently discovered by genome sequencing...
Identification of non-coding RNAs embracing microRNA-143/145 clusterAkio Iio
Department of Medical Oncology, Gifu International Institute of Biotechnology, 1 1 Naka fudogaoka, Kakamigahara, Gifu 504 0838, Japan
Mol Cancer 9:136. 2010....
Normal and oncogenic FLT3T Naoe
Department of Hematology, Nagoya University, Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8550, Japan
Cell Mol Life Sci 61:2932-8. 2004..Exploring the mechanism by which FLT3 mutations cause autoactivation and uncontrolled signaling might lead to a better understanding of how FLT3 becomes oncogenic and provide insights for the development of new drugs...
Nucleophosmin: a versatile molecule associated with hematological malignanciesTomoki Naoe
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer Sci 97:963-9. 2006..This review focuses on the clinical significance of the NPM1 gene in hematological malignancies and newly discovered roles of NPM associated with oncogenesis...
Leukemia relapse reconsidered from the molecular aspectT Naoe
Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya 466 8560, Japan
Leuk Lymphoma 37:527-34. 2000..Studies on leukemia relapse have thus served as a model of clonal progression, which can be serially observed, including selection by chemotherapy, induction of resistant phenotype, and genetic alteration...
Developing target therapy against oncogenic tyrosine kinase in myeloid maliganaciesTomoki Naoe
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Tsurumai cho 65, Showa Ku, Nagoya 466 8550, Japan
Curr Pharm Biotechnol 7:331-7. 2006..Challenging studies with TKIs have also been reported for acute myeloid leukemia. This review will focus on recent trials of TKIs against oncogenic tyrosine kinases (ABL, PDGFRs, FLT3 and KIT) in myeloid malignancies...
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapyT Naoe
Department of Infectious Diseases, Nagoya University School of Medicine, Japan
Cancer Chemother Pharmacol 48:S27-30. 2001..Another HSP90 inhibitor, radicicol, also induced apoptosis selectively in transformed 32D cells. HSP90 is a promising target for the treatment of AML with mutant FLT3...
Mechanism-based therapy for leukemia: a lesson from ATRA therapyT Naoe
Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Japan
Nagoya J Med Sci 64:103-8. 2001..Basic and clinical research into ATRA-resistance provides new directions for acute myeloid leukemia therapy. Anti-leukemia therapy will continue to lead the field of chemotherapy in the coming decades...
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantationY Inamoto
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
Bone Marrow Transplant 39:25-30. 2007..In summary, addition of HDCA is not beneficial for high-risk patients, and is not recommended for standard-risk patients receiving unrelated transplantation...
Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitorsY Minami
Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya, Japan
Leukemia 16:1535-40. 2002..These findings imply that targeting of Hsp90 will facilitate the development of anti-TDFLT3 therapy, and that Hsp90 is closely involved in the oncogenic activation of FLT3...
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITDM Okamoto
1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Leukemia 21:403-10. 2007..These results demonstrate that Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD...
In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid miceH Kosugi
First Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya 466-8560, Japan
Jpn J Cancer Res 92:529-36. 2001..These findings suggest that FK228 is a promising agent to enhance ATRA-sensitivity in the treatment of APL...
Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipientsS Terakura
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Bone Marrow Transplant 37:381-6. 2006..These results suggest that a GSTM1-null genotype in recipients protects against TRM after allogeneic HSCT. Further studies are needed to elucidate a mechanism of increased risk for TRM in GSTM1-positive recipients...
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto
Department of Infectious Diseases and the First Department of Internal Medicine, Nagoya University School of Medicine, Japan
Blood 97:2434-9. 2001..These results demonstrate that the FLT3 gene is the target most frequently mutated to become constitutively active in AML...
TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathwaysT Kanie
Department of Hematology, Graduate School of Medicine, Nagoya University, Nagoya, Japan
Leukemia 18:548-55. 2004..These data suggest that TEL-Syk fusion protein in the cytoplasm leads to the constitutive activation of PI3-K/Akt, MAPK and STAT5 signal pathways, which are closely involved in IL-3-independent cell proliferation of BaF3 cells...
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe
Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya, Japan
Leukemia 16:203-8. 2002..073; within 120 days, P = 0.028), whereas CR rates and relapse frequencies were similar. The null genotype of GSTT1 might be associated with increased toxicity after chemotherapy...
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host diseaseM Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Bone Marrow Transplant 36:867-72. 2005..Thus, patients who developed extensive chronic GVHD had better survivals (P = 0.0217), and those who developed grade III-IV acute GVHD had worse survivals (P = 0.0023) than did the others...
Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantationY Atsuta
Department of Preventive Medicine Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Tsurumai cho, Showa Ku, Nagoya, Japan
Bone Marrow Transplant 37:289-96. 2006..Our patients could not be accurately classified when the proposed prognostic models from Western countries were used, thus indicating the need for a different model to identify high-risk patients...
Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCTM Murase
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Bone Marrow Transplant 46:1444-9. 2011..As the presence of the C-A-A haplotype reduced relapse risk and improved survival after allogeneic HSCT, this CTLA-4 haplotype may provide useful information for donor selection...
Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient miceM Ninomiya
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Tsurumai cho, Showa Ku, Nagoya, Japan
Leukemia 21:136-42. 2007..These findings suggest that xenotransplantation into immunodeficient mice provides a useful model to study the leukemia niche...
Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cellsM Murata
First Department of Internal Medicine, Nagoya University School of Medicine, Nagoya 466-8550, Japan
Jpn J Cancer Res 91:1154-60. 2000..This novel agent might be useful in the treatment of lymphoid malignancies, because the above concentrations are clinically achievable in vivo according to a recent clinical study...
Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathyY Inamoto
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya 466 8560, Japan
Bone Marrow Transplant 44:43-9. 2009..Avoiding intensified immunosuppression that damages vascular endothelium until the resolution of i-TAM may improve transplant outcome...
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignanciesS Terakura
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan
Ann Oncol 22:1865-71. 2011..Thus we examined that modified continual reassessment method (mCRM) is applicable for deciding appropriate conditioning of allogeneic BM transplantation...
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4Momoko Suzuki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya 466 8550, Japan
Eur J Haematol 84:229-38. 2010..We investigated the mechanism responsible for imatinib (IM) resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL) cell lines...
Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHDY Inamoto
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Bone Marrow Transplant 45:363-9. 2010..In conclusion, more active homing of CCR9-926AG T cells to Peyer's patches may produce changes in Ag presentation and result in increased incidence of skin GVHD...
Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysisM Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Leukemia 19:1345-9. 2005..Although it should be borne in mind that this meta-analysis was based on data abstracted from observational studies, these results may justify the risk-adapted therapeutic strategies for AML according to the FLT3 status...
Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosisK Shimada
Nagoya Blood and Marrow Transplantation Group NBMTG, Nagoya, Japan
Bone Marrow Transplant 36:115-21. 2005..8%. Our data suggest that early detection of secondary cancers is very important in prolonging overall survival...
p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutationA Furuhata
Nagoya University Graduate School of Medicine, Nagoya University School of Health Sciences, Nagoya, Japan
Biochem Biophys Res Commun 383:411-6. 2009..Similar findings were observed in BCR/ABL-transfected Ba/F3. Our results elucidate the regulatory mechanism by which JAK2V617F modulates Skp2 gene expression through the STAT transcription factors...
L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand diseaseT Kashiwagi
Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
Haemophilia 14:556-63. 2008..Protein instability of L1503R may be responsible for its intracellular retention and perhaps the larger VWF multimers, containing more mutant VWF subunits, are likely to be mal-processed and retained within the cell...
In vitro characterization of missense mutations associated with quantitative protein S deficiencyH Okada
Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
J Thromb Haemost 4:2003-9. 2006..To elucidate the molecular consequences of hereditary protein S (PS) deficiency, we investigated the in vitro synthesis of the PS missense mutants in COS-1 cells and their activated protein C (APC) cofactor activities...
Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapyMasamitsu Yanada
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Br J Haematol 143:503-10. 2008....
Prognostic implication and biological roles of RhoH in acute myeloid leukaemiaToshihiro Iwasaki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Eur J Haematol 81:454-60. 2008..e. high GTP-Rac) contributes to chemotherapy resistance in leukaemia cells. Our result suggests that inhibition of Rac and its signalling components might provide a useful anti-leukaemic strategy...
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in JapM Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Bone Marrow Transplant 34:331-7. 2004..62, 95% CI: 1.23-2.14, P=0.0007 for OS). This superiority of FK506 was not observed in SIB-HSCT cases. These findings indicate that the use of FK506 instead of CSP for GVHD prophylaxis is beneficial for patients undergoing UD-HSCT...
Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia BK Okumura
Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
Haemophilia 14:1088-93. 2008..This crossing-over was absent in the other twin, consistent with their fraternal state. Differently skewed X inactivation in the fraternal female twins might cause moderately severe and mild haemophilia B phenotypes, respectively...
Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1T Kajiguchi
The First Department of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
Leukemia 17:2189-95. 2003..This finding may provide a basis to select a subgroup other than acute promyelocytic leukemia, which can benefit from As(2)O(3) treatment...
Altered interaction of HDAC5 with GATA-1 during MEL cell differentiationKouichi Watamoto
Department of Molecular Medicine, Graduate School of Medicine, Nagoya University, Nagoya 466 8550, Japan
Oncogene 22:9176-84. 2003..These observations support the suggestion that control of the HDAC5 nucleocytoplasmic distribution might be associated with MEL cell differentiation, possibly through regulated GATA-1 transactivation...
Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemiaMasayuki Towatari
Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan
Blood 104:3507-12. 2004..This is especially useful because it provides the patients with a better chance to receive an allogeneic HSC transplant...
BMI-1 is highly expressed in M0-subtype acute myeloid leukemiaMasashi Sawa
Department of Molecular Medicine and Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 82:42-7. 2005..These results indicated that a subgroup of M0 patients has a high expression level of polycomb group gene BMI-1, which may contribute to leukemogenesis...
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura
Department of Haematology, Nagoya University Graduate School of Medicine, Aichi, Japan
Br J Haematol 129:221-8. 2005..Thus, the enzyme function of UGT2B17 in donor cells may affect the outcome of allogeneic HSCT...
Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivoAkihide Atsumi
Department of Hematology, Nagoya University Graduate School of Medicine, Showa Ku, Japan
Biochem Biophys Res Commun 345:1471-80. 2006..These results provide evidence to show that the N-CoR/HDAC3 co-repressor complex is involved in the aberrant transcription regulation in PML-RARalpha-expressing cells...
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapyMasamitsu Yanada
Nagoya University Graduate School of Medicine, Nagoya, Japan
Haematologica 93:287-90. 2008..027), and increase the risk of treatment failure by 2.8-fold...
Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adultsK Sugimoto
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Bone Marrow Transplant 41:729-36. 2008..047). These results suggest that chronic GVHD following CBT is mild and has a graft-versus-malignancy effect...
High incidence of secondary failure of platelet recovery after autologous and syngeneic peripheral blood stem cell transplantation in acute promyelocytic leukemiaH Narimatsu
Department of Hematology and Oncology, JA Aichi Showa Hospital, Konan, Japan
Bone Marrow Transplant 40:773-8. 2007..The unexpectedly high prevalence and the characteristics of SFPR may provide additional information on management following autologous SCT for acute myeloid leukemia...
Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndromeM Iwai
Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Japan
Leukemia 19:1367-75. 2005..These results suggested that FHIT methylation was accumulated through the disease progression of MDS and AML, and the role of the FHIT gene as a tumor suppressor seemed different in AML and MDS...
Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell lineM Ninomiya
Department of Hematology, Nagoya University Hospital, Nagoya, Japan
Leukemia 18:442-8. 2004..These findings suggested that the activation of adhesion molecules for leukocytes and expression of CXC chemokines in the lung are closely involved in triggering RAS...
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta
Department of Hematology, Fujita Health University Hospital, Toyoake, Aichi, Japan
Leukemia 25:41-7. 2011..265). Imatinib-based therapy is a potentially useful strategy for newly diagnosed patients with Ph+ALL, not only providing them more chance to receive allo-HSCT, but also improving the outcome of allo-HSCT...
PAX5-PML acts as a dual dominant-negative form of both PAX5 and PMLS Kurahashi
Department of Hematology and Oncology, Nagoya University, Graduate School of Medicine, Nagoya, Aichi, Japan
Oncogene 30:1822-30. 2011..These data suggest the possible involvement of this fusion protein in the leukemogenesis of B-ALL in a dual dominant-negative manner and the possibility that ALL with PAX5-PML can be treated with ATO...
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylationTakumi Sugimoto
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Biochem Biophys Res Commun 390:48-53. 2009..These results suggest that recruitment of the Sin3A-HDAC1 complex is related to downregulation of CD20 expression in CD20-negative B-cells after treatment with rituximab...
Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study GroupYasuyoshi Morita
Department of Hematology, Kinki University School of Medicine, 377 2 Ohno Higashi, Osaka Sayama, Osaka, 589 8511, Japan
Int J Hematol 91:97-103. 2010..In conclusion, it is necessary to introduce the first line therapy excluding the chemotherapy that can prolong survival in patients with high-risk MDS and MDS-AML...
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemiaKazutaka Ozeki
Department of Infectious Diseases, Nagoya University School of Medicine, Japan
Blood 103:1901-8. 2004..These results indicated that FLT3 overexpression may distinguish a novel disease entity in AML without FLT3 mutations and serve as a therapeutic target for FLT3 inhibitors...
Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomibH Mizuno
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Leukemia 26:2269-76. 2012..These results provide further evidence supporting causal relationships between inflammation and tumor growth, and demonstrate that bortezomib can target the tumor microenvironment...
Allogeneic myeloablative transplantation for patients aged 50 years and overM Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Bone Marrow Transplant 34:29-35. 2004..0303, respectively). These findings indicate that allogeneic c-HSCT should be offered to patients over 50 years only if the increased risk of TRM is acceptable, and that a non-TBI regimen is preferable when the transplant is performed...
B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cellsY Hirose
Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya, Japan
Immunology 104:410-7. 2001..These results indicated that immature features of pre-B cells from CB, such as lack of TdT expression, and a short N region and few productive rearrangements in the IgH gene, might cause the delay in mature B-cell production...
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell linesF Hayakawa
First Department of Internal Medicine, Nagoya University School of Medicine, Japan
Oncogene 19:624-31. 2000..Finally, we found constitutive activation of MAP kinase and STAT5 in all clinical samples of AML patients with mutant Flt3. Our study shows the significance of internal tandem duplication of Flt3 receptors for leukemia cell expansion...
Transcriptional regulation of FKLF-2 (KLF13) gene in erythroid cellsAyako Mitsuma
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Biochim Biophys Acta 1727:125-33. 2005..These findings provide an insight on the mechanism of inducible mRNA expression of the KLF13 gene in erythroid cells...
Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemiaMasahiro Kajiguchi
Department of Cardiology, Nagoya University Graduate School of Medicine, Japan
Circ J 71:196-201. 2007..However, because one-third of treated patients fail to respond, the present study was an exploration of the characteristics of responders and non-responders to this treatment regimen...
Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donorYoshihiro Inamoto
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Aichi, Japan
Int J Hematol 83:356-62. 2006....
Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphomaToshihito Ohno
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 83:341-7. 2006..09; P = .0258). Lack of MGMT protein expression is associated with aberrant promoter DNA methylation and appears to be a useful marker for predicting the survival of DLBCL patients...
GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell linesA Furuhata
Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya, Japan
Leukemia 23:1270-7. 2009..Taken together, these results suggest that GATA-1 and/or GATA-2 binding to a GATA site of the 3' enhancer of WT1 played an important role in WT1 gene expression...
Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell linesTomohiro Kajiguchi
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, 466 8550, Japan
Cancer Sci 97:540-5. 2006..Cotreatment with ATO and the agent, which can induce sustained activation of JNK, might improve the outcome in MM therapy...
Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion geneManabu Ninomiya
Department of Hematology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
Cancer Genet Cytogenet 169:1-11. 2006..These results suggest that TRL-01 is a useful cell line for studying not only the leukemia-related biology of MLL-ENL but also the intercellular association between leukemia and stroma...
Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotypeKyoko Sugimoto
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya, Aichi 466 8550, Japan
Int J Hematol 87:451-8. 2008..These results suggest that greater immunosuppression by methotrexate due to low MTHFR enzyme activity decreases the risk of acute GVHD in recipients of allogeneic HSCT...
Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemiaYuichi Ishikawa
Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Japan
Eur J Haematol 83:90-8. 2009..These results collectively suggest that TP53 mutation might be a functionally distinguishable class of mutation...
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 studNorio Asou
Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan
Blood 110:59-66. 2007....
Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemiaTakashi Iwasaki
Department of Laboratory Medicine, Nagoya University School of Medicine, Nagoya, Japan
Pathol Int 57:645-51. 2007....
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantationYoshihiro Inamoto
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8560, Japan
Am J Hematol 84:283-6. 2009..100%, P = 0.0001). Combinations of cytogenetics and ISS could readily predict prognosis. Quality of response is a poor surrogate marker for ultimate outcome. High-risk patients may need more effective treatment...
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantationM Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Bone Marrow Transplant 32:801-7. 2003..Optimal pre-emptive strategy needs to be determined...
Immunoglobulin variable region structure and B-cell malignanciesH Kiyoi
Department of Infectious Diseases, Nagoya University School of Medicine, Japan
Int J Hematol 73:47-53. 2001..As the complete nucleotide sequences of the human Ig heavy and Ig light V region loci have now been determined, the study of Ig genetics has entered into the super-information era...
A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V geneN Yamakage
Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, and Division of Transfusion Medicine, Nagoya University Hospital, Japan
Haemophilia 12:172-8. 2006..Taken together, it seems to suggest that each gene mutation could be separately responsible for severe FV deficiency, while this phenotype is due to the in-trans combination of the two defects...
FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cellsT Kajiguchi
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Leukemia 21:2476-84. 2007..These data demonstrate that FLT3 activation induces beta-catenin tyrosine phosphorylation and nuclear localization, and thus suggest a mechanism for the association of FLT3 activation and beta-catenin oncogeneic signaling in AML...
Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature reviewMakoto Murata
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466 8550, Japan
Int J Hematol 88:111-5. 2008..Peripheral blood stem cells might have an advantage in that they are associated with a low incidence of DCL development because PBSCT recipients receive a higher total cell dose than recipients of bone marrow or cord blood cells...
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO studyYuichi Ishikawa
Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer Sci 101:2186-92. 2010..A prospective intervention study is required to establish PK-based management in CML patients treated with imatinib...
[Circumventing resistance to imatinib therapy in chronic myeloid leukemia]Yosuke Minami
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Gan To Kagaku Ryoho 36:544-7. 2009..A multitude of novel agents have been developed and shown efficacy in overcoming imatinib resistance...
Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndromeJinglan Xu
Department of Haematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Br J Haematol 140:394-401. 2008..These findings suggest that in situ detection of nuclear NPBC by immunohistochemistry could provide new insights into the pathogenesis and prognosis of AML and MDS...
Presentation and management of intravascular large B-cell lymphomaKazuyuki Shimada
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Lancet Oncol 10:895-902. 2009..This Review describes the cutting edge of research on IVLBCL, and discusses the unsolved issues from biological and clinical perspectives to provide a better understanding of this rare lymphoma...
Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphomaKazuyuki Shimada
Department of Hematology, Ogaki Municipal Hospital, Gifu, Japan
J Clin Exp Hematop 48:25-8. 2008..She has remained in complete remission for over 3 years after diagnosis. This report suggests that rituximab-containing regimens could be safe and effective for elderly patients with IVL...
The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0Ritsuro Suzuki
Department of HSCT Data Management, Nagoya University School of Medicine, 1 1 20 Daiko Minami, Higashi ku, Nagoya 461 0047, Japan
Int J Hematol 91:303-9. 2010..The poor prognosis of CD7(+) CD56(+) M1-M7 suggests that this phenotype may act as a prognostic factor for AML, but this should be confirmed in further studies...
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapyAkihiro Abe
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 88:471-5. 2008..Our results implicate that the sorted and purified stem cells are useful for more sensitive quantification of BCR-ABL-positive minimal residual disease...
Abnormal cytoplasmic dyslocalisation and/or reduction of nucleophosmin protein level rarely occurs in myelodysplastic syndromesYuichi Ishikawa
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, and Department of Infectious Diseases, Nagoya University Hospital, Showa Ku, Nagoya, Japan
Leuk Lymphoma 49:2359-64. 2008..It was concluded that abnormal cytoplasmic localisation and/or significant reduction of NPM1 protein level rarely occurs in MDS. The increase in the number of nuclear NPM1-positive cells may be related to the progression of MDS...
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosisFumihiko Hayakawa
Department of Hematology and Oncology, Nagoya University, Graduate School of Medicine, Nagoya 466 8550, Japan
J Biol Chem 283:24420-5. 2008..Our work provides new insights into PML regulation by post-translational modification and new information about the therapeutic mechanism of HDAC inhibitors...
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in JapanKazuyuki Shimada
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8550 Japan
J Clin Oncol 26:3189-95. 2008..To evaluate the safety and efficacy of rituximab-containing chemotherapies for intravascular large B-cell lymphoma (IVLBCL)...
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significanceJunji Hiraga
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan
Blood 113:4885-93. 2009..These findings suggest that some epigenetic mechanisms may be partly related to the down-regulation of CD20 expression after rituximab treatment...
Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomographyKazuyuki Shimada
Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japan
Int J Hematol 88:149-53. 2008..These results suggest false-negative results for some types of organ involvement. Careful interpretation of the results of FDG-PET in IVLBCL is thus required...
Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatmentYosuke Minami
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8550, Japan
Int J Hematol 92:664-6. 2010..These results suggest that the monitoring of gene mutations in HSC and progenitors at diagnosis might be helpful for the early detection of TKI-resistant CML patients and facilitate appropriate therapeutic decision...
Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in JapanHiroto Narimatsu
Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan
Int J Hematol 88:154-8. 2008..Although these findings need to be confirmed with a larger number of patients, our data indicate that the MRD level at a given time during the early course in CR does not predict the outcome in Japanese patients...
Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapyAkihiro Tomita
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 86:49-57. 2007..Thus, RRBL1 may be useful not only for analyses of mechanisms for the absence of CD20 expression in vitro but also for exploration of therapies against CD20- B-cell malignancies in vivo...
Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO miceTadashi Matsushita
Department of Hematology, Nagoya University Graduate School of Medicine, Japan
Biochem Biophys Res Commun 325:1163-71. 2004..Such observation may parallel the diverse expression of Alport's manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs...
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysisMasamitsu Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer 103:1652-8. 2005..Because the karyotype identified at diagnosis is the most relevant prognostic factor for AML, it should be possible to assess the efficacy more accurately on the basis of cytogenetic risk...
Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantationKoji Yamamoto
Department of Transfusion Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya 466 8550, Japan
Arterioscler Thromb Vasc Biol 24:e192-6. 2004..It is also important to evaluate endothelial progenitor cell (EPC) contents in different stem cell sources to choose the best material for therapeutic angiogenesis...
Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentationMasamitsu Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Eur J Haematol 77:282-7. 2006..Although there are two major scoring systems for the clinical diagnosis of disseminated intravascular coagulation (DIC), the validity of these systems for leukemia-associated DIC remains to be confirmed...
Classic polyarteritis nodosa presenting rare clinical manifestations in a patient with hemophilia ATadashi Matsushita
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 83:420-5. 2006..Concomitant hemorrhagic and thrombotic manifestations of cPAN are hardly treatable in patients with coagulation disorders, and the current case may represent a rare transfusion-related complication in hemophilia patients...
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutationHitoshi Kiyoi
Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 83:301-8. 2006....
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysisMasamitsu Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer 106:2657-63. 2006..Therefore, optimal postremission therapy is a matter of vital concern. In particular, the clinical efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) should be clarified...
Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experienceMasamitsu Yanada
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Eur J Haematol 74:418-23. 2005..Our findings suggest that the WHO classification may be strengthened by greater emphasis on genetic/cytogenetic information...
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemiaTatsuya Suzuki
Department of Infectious Diseases, Nagoya University School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8560, Japan
Blood 106:2854-61. 2005..These results suggest that the NPM1 mutation is not necessarily an early event during leukemogenesis or that leukemia clones with NPM1 mutations are sensitive to chemotherapy...
Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in JapaneseAsahi Hishida
Department of Molecular Medicine and Clinical Science, Nagoya University Graduate School of Medicine, Nagoya, Japan
Leuk Lymphoma 45:957-64. 2004..08; 95% CI, 1.11-3.90, P = 0.023). Further examination with a sufficiently larger population and other ethnicities are required to confirm our findings...
Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphomaJunji Hiraga
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Hematol 84:248-55. 2006..88, and P = .31, respectively). MGMT promoter hypermethylation and p53 mutation are useful prognostic markers in DLBCL. The impact of MGMT inactivation on p53 mutation in DLBCL is unclear...
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemiaYosuke Minami
Department of Hematology, Nagoya University Graduate School of Medicine, Tsurumai cho 65, Showa Ku, Nagoya 466 8550, Japan
Blood 102:2969-75. 2003..These findings suggest that the antiapoptotic pathways from FLT3/ITD are more divergent than those from WtFLT3 and may represent targets for drug discovery with the potential of inducing selective cell death of human leukemia cells...
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutationsHitoshi Kiyoi
Department of Infectious Diseases, Nagoya University School of Medicine, Japan
Clin Cancer Res 13:4575-82. 2007..The aim of this study was to evaluate the antileukemia activity of a novel FLT3 kinase inhibitor, FI-700...
Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domainHitoshi Kiyoi
Department of Infectious Diseases, Nagoya University School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8560, Japan
Oncogene 21:2555-63. 2002..These findings indicate that the FLT3 JM domain plays an important role in receptor activation, and that the length-mutated JM domain induces ligand-independent receptor activation but also activates Wt-FLT3 in a trans-manner...
FLT3 in human hematologic malignanciesHitoshi Kiyoi
Department of Infectious Diseases, Nagoya University School of Medicine, Japan
Leuk Lymphoma 43:1541-7. 2002..In this review, we summarize the clinical and biological significance of FLT3-mutations and discuss the possibility of targeting FLT3 kinase for the treatment of leukemia...
